Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Etiology of mediastinal lymph node enlargement in patients who underwent EBUS-TBNA

Marta Dabrowska, Katarzyna Faber, Martyna Tandejko-Burdyna, Piotr Korczynski, Rafal Krenke
European Respiratory Journal 2019 54: PA3095; DOI: 10.1183/13993003.congress-2019.PA3095
Marta Dabrowska
1Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mdabrowska@mp.pl
Katarzyna Faber
1Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martyna Tandejko-Burdyna
2Student’s Scientific Group „Alveolus”, Medical University of Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Piotr Korczynski
1Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafal Krenke
1Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: Mediastinal lymphadenopathy (ML), may be caused either by malignant or benign diseases. It usually is diagnosed by chest computed tomography and bronchoscopy with endobronchial ultrasound guided TBNA (EBUS-TBNA).

Aim: The aim of the study was to analyze causes of ML in patients, in whom bronchoscopy with EBUS-TBNA was performed.

Patients and Methods: A retrospective analysis of all patients, who had ML and underwent bronchoscopy with EBUS-TBNA between 2009 and 2017 was performed.

Results: 1075 (596 M, 479 F) patients who underwent EBUS-TBNA were included in the analysis. The most common cause of ML were malignant diseases (n=662, 61.6%). Lung cancer was diagnosed in 572 (53%) patients, while 90 (8.4%) patients had other malignancies.

Non-malignant diseases were diagnosed in 356 (33.1%) patients. In this group the most common diagnosis was sarcoidosis -250 patients (23.3%). Infectious diseases were documented in 32 cases (3%) and included: tuberculosis (17), MOTT (2), pneumoniae (10), pulmonary invasive mycosis (2) and mononucleosis (1). In 51 (4.7%) patients ML was associated with heart failure. 23 patients (2.1%) had other diseases that could have explained ML (among them interstitial lung diseases were the most common).

In 57 (5.3%) etiology of ML could not have been determined due to lack of pathologic diagnosis or follow-up.

Conclusions: The most common cause of ML were malignant diseases. Sarcoidosis and HF accounted for the majority of benign ML causes, while infections only occasionally were diagnosed as the cause of ML.

  • Bronchoscopy
  • Mediastinal tumour

Footnotes

Cite this article as: European Respiratory Journal 2019; 54: Suppl. 63, PA3095.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2019
Previous
Back to top
Vol 54 Issue suppl 63 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Etiology of mediastinal lymph node enlargement in patients who underwent EBUS-TBNA
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Etiology of mediastinal lymph node enlargement in patients who underwent EBUS-TBNA
Marta Dabrowska, Katarzyna Faber, Martyna Tandejko-Burdyna, Piotr Korczynski, Rafal Krenke
European Respiratory Journal Sep 2019, 54 (suppl 63) PA3095; DOI: 10.1183/13993003.congress-2019.PA3095

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Etiology of mediastinal lymph node enlargement in patients who underwent EBUS-TBNA
Marta Dabrowska, Katarzyna Faber, Martyna Tandejko-Burdyna, Piotr Korczynski, Rafal Krenke
European Respiratory Journal Sep 2019, 54 (suppl 63) PA3095; DOI: 10.1183/13993003.congress-2019.PA3095
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Evaluating the presence of SARS-CoV-2 RNA in the pleural fluid of patients undergoing pleural procedures without symptoms of COVID-19
  • Subclinical myasthenia gravis in thymomas
  • How successful are medical thoracoscopists at predicting non-expandable lung?
Show more Pleural and mediastinal malignancies

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society